Belpointe Asset Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,347
Closed -$899K 1009
2025
Q2
$899K Buy
2,347
+126
+6% +$45.4K 0.04% 394
2025
Q1
$767K Buy
+2,221
New +$714K 0.04% 415
2023
Q3
Sell
-1,008
Closed -$306K 683
2023
Q2
$306K Sell
1,008
-1,094
-52% -$304K 0.03% 443
2023
Q1
$554K Buy
2,102
+12
+0.6% +$3.05K 0.03% 523
2022
Q4
$501K Sell
2,090
-102
-5% -$22.8K 0.03% 540
2022
Q3
$402K Buy
2,192
+115
+6% +$22.9K 0.03% 588
2022
Q2
$349K Sell
2,077
-504
-20% -$108K 0.02% 623
2022
Q1
$646K Sell
2,581
-280
-10% -$70.3K 0.04% 452
2021
Q4
$735K Sell
2,861
-5,768
-67% -$1.41M 0.05% 407
2021
Q3
$2.1M Buy
8,629
+5,719
+197% +$1.4M 0.14% 149
2021
Q2
$602K Buy
2,910
+68
+2% +$13.9K 0.04% 438
2021
Q1
$535K Sell
2,842
-100
-3% -$17.6K 0.05% 410
2020
Q4
$484K Buy
+2,942
New +$430K 0.04% 414
2019
Q3
Sell
-3,425
Closed -$463K 689
2019
Q2
$463K Buy
+3,425
New +$433K 0.09% 243

Other funds holding HCA

Belpointe Asset Management's HCA Position: Q3 2025 in Review

Belpointe Asset Management sold out of HCA Healthcare (HCA) in Q3 2025, closing a stake of 2,347 shares — an estimated $899K sold.

Belpointe Asset Management first reported a position in HCA in Q2 2019 and held it in 14 quarters. The position peaked at $2.1M in Q3 2021. 1,286 funds tracked by Wall St. Rank hold HCA as of Q3 2025.

  • Belpointe Asset Management reported no remaining HCA Healthcare position as of Q3 2025 after selling out during the quarter.
  • Belpointe Asset Management sold 2,347 HCA Healthcare shares in Q3 2025, an estimated $899K.
  • Belpointe Asset Management first reported a position in HCA Healthcare in Q2 2019 and held it in 14 quarters.
  • Belpointe Asset Management's HCA Healthcare position peaked at $2.1M in Q3 2021.
  • 1,286 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2025.

Based on Belpointe Asset Management's 13F filing for Q3 2025, filed 3 Nov 2025.